Trevi
Trevi Therapeutics
TRVI pharma USA
Quick answer
Trevi is a pharma company (TRVI) headquartered in NEW HAVEN, CT, USA with 10 tracked pipeline programs.
Pipeline (10)
project
Nalbuphine ER Tablets
Prurigo Nodularis
1 trials projectnalbuphine HCl ER
Uremic Pruritus
2 trials projectnalbuphine HCl ER
Prurigo Nodularis
1 trials projectnalbuphine HCl ER tablets 60 mg BID
Uremic Pruritus
1 trials projectnalbuphine HCl ER tablets 90 mg BID
Prurigo Nodularis
1 trials projectNAL ER
Idiopathic Pulmonary Fibrosis
3 trials projectNAL ER
Refractory Chronic Cough
1 trials projectNAL ER
Healthy Participants
2 trials projectNalbuphine ER
Hepatic Impairment
1 trials projectNalbuphine HCl solution
Nalbuphine
1 trialsPatents (7)
patent
US 12274696
Methods of administering nalbuphine
patentUS 11660296
Treatment of chronic cough, breathlessness and dyspnea
patentUS 10238646
Methods for treating pruritus
patentUS 9624233
Compounds for treating pruritic conditions
patentUS 8987289
Methods for treating pruritus
patentUS 8940753
Methods for treating pruritis
patentUS 8637538
Methods for treatment of pruritis